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MASH1 maintains competence for BMP2-induced neuronal
differentiation in post-migratory neural crest cells
Liching Lo, Lukas Sommer* and David J. Anderson
Background: The interplay between growth factors and transcription factors in
vertebrate neurogenesis is poorly understood. MASH1 is a basic
helix–loop–helix (bHLH) transcription factor that is essential for autonomic
neurogenesis. Bone morphogenetic protein (BMP) 2, and its relative BMP4,
have been shown to induce expression of MASH1 and to promote autonomic
neuronal differentiation in neural crest stem cells. The relationship between
expression of MASH1 and the neurogenic competence of neural crest cells has
not been investigated, however.
Results: We have examined the function of MASH1 in neurogenic
competence using a population of immuno-isolated neural-crest-derived
progenitor cells. Post-migratory neural crest cells isolated from fetal rat gut
expressed Mash1, yet comprised a mixture of committed neuronal precursors
and non-neuronal cells. The non-neuronal cells remained competent to
differentiate to neurons, however, if challenged with BMP2. Such competence
declines with time and is paralleled by a decline in Mash1 expression in the
cells. Expression of endogenous Mash1 can be maintained by BMP2; in turn,
constitutive expression of Mash1 from a retroviral vector maintains competence
for neuronal differentiation in response to late addition of BMP2.
Conclusions: These data suggest that MASH1 promotes competence for
neurogenesis, in a manner similar to its homologs, the proneural genes
achaete–scute in Drosophila. They also reveal an unexpected feedback
interaction between BMP2 and MASH1 during neuronal differentiation. MASH1
may play multiple roles at successive stages of development within a
neurogenic lineage, only one of which is revealed by a loss-of-function mutation.
Background
An important problem in developmental biology is to
explain in terms of the actions of specific genes the pro-
gressive changes in the competence and commitment of
undifferentiated progenitor cells to adopt particular fates.
This problem is a challenging one, because ‘competence’
and ‘commitment’ are cellular properties that are opera-
tionally defined by transplanting or culturing cells or
tissues, while gene action is defined by loss-of-function or
gain-of-function mutations which are usually analyzed in
the context of an intact embryo. To bridge these levels of
analysis, it is necessary both to manipulate progenitor cells
genetically and to challenge them by altering their envi-
ronment. There are relatively few experimental systems
in which such manipulations have been feasible, however.
Transcription factors in the basic helix–loop–helix (bHLH)
family have been identified as key determinants of cell
fate (for reviews, see [1–3]). In Drosophila, bHLH proteins
encoded by the proneural genes of the achaete–scute
complex are necessary for neural cell fate determination
(for review, see [4]). Expression of achaete–scute genes in
neuroectodermal cells is insufficient to commit them to a
neural fate. It is thought, however, that these genes confer
competence to adopt a neural fate, because in neurogenic
mutants (such as Notch–), most or all cells of the proneural
cluster become sensory organ precursors, and this conver-
sion is dependent on achaete–scute function (reviewed in
[5]). In addition, commitment to a neural fate is correlated
with increased levels of achaete–scute expression [6].
Whether such a quantitative increase in proneural gene
expression is actually responsible for commitment, how-
ever, has not yet been established.
In mammals, forced expression of muscle-specific bHLH
factors, such as MyoD, can promote myogenic differentia-
tion in a variety of heterologous cell types (reviewed in
[7]). MyoD is therefore sufficient to confer competence for
myogenesis. As in the case of achaete–scute expression and
Drosophila neurogenesis, it is thought that expression of
MyoD above a threshold level is required for commitment
to myogenic differentiation [2]. The precise relationship
between expression of myogenic bHLH genes and the
state of commitment to a muscle fate is not clear, however,
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because of the difficulty of isolating embryonic muscle pre-
cursor cells at the time that they first express such genes.
The neural crest is a system in which multipotent pro-
genitor cells become competent and then committed to
generate one of several alternative fates. Mash1, a mam-
malian homolog of achaete–scute [8], is expressed in precur-
sors of autonomic neurons that derive from the neural
crest [9] and is essential for the differentiation of these
neurons [10–12]. It is not clear whether Mash1 confers
competence for neurogenesis or is only required for overt
differentiation. In part, this has reflected the lack of
appropriate cell populations in which to perform gain-of-
function manipulations for this gene [13].
Previously, we isolated a population of post-migratory
neural-crest-derived precursors of autonomic (enteric)
neurons from the developing gut, using monoclonal anti-
bodies to the receptor tyrosine kinase c-RET [14]. Most
(≥ 85%) of such cells express Mash1 at the time of their
isolation. Approximately 30–50% of the cells behave as
committed neuronal precursors [14]; however, the remain-
der divide to produce clones containing non-neuronal
cells. These observations suggested that Mash1 expression
is insufficient to commit neural crest cells to a neuronal
fate; however, they left open the issue of whether the non-
neuronal cells that express Mash1 are competent for neu-
rogenesis or, rather, are committed to a non-neuronal fate.
We have now used BMP2, which promotes autonomic
neurogenesis in cultures of premigratory neural crest stem
cells (NCSCs) [15], to challenge the non-neurogenic
subpopulation of c-RET+ cells and to determine whether
they are competent for neurogenesis. Surprisingly, virtu-
ally all such cells are competent to differentiate into
neurons when exposed to BMP2. Neurogenic competence
declines with time in culture, however, and is paralleled
by a gradual extinction of Mash1 expression in these cells;
extinction of Mash1 expression can be prevented by main-
taining the cells in BMP2. Forced expression of Mash1
from a retroviral vector prevents this progressive loss of
neurogenic competence. These results suggest that Mash1
maintains competence for neurogenesis in post-migratory
neural crest cells. Moreover, the data reveal an unex-
pected positive-feedback interaction between BMP2 and
MASH1, which may underlie the progressive commitment
of the progenitor cells to a neuronal fate.
Results
Non-neuronal cells expressing c-RET are capable of
differentiating into smooth muscle or glia
As described previously [14], approximately 50% of
c-RET+ cells divide to generate clones of flat, non-
neuronal cells (Fig. 1). These clones could contain differ-
entiated non-neuronal cell types, precursors of neurons
which failed to undergo overt differentiation, or both. We
therefore stained such clones with antibody markers for
smooth muscle or glia, two non-neuronal cell types pro-
duced by NCSCs under similar culture conditions [15–17].
We found that 35 ± 5% (2 experiments, 85 colonies
counted) of non-neuronal clones contained cells that
expressed both smooth muscle actin (SMA) and calponin
after 4 days in standard culture medium (Fig. 2a,b). In
separate experiments, 10 ± 2% (2 experiments, 121
Figure 1
Morphology of a typical non-neuronal clone in
cultures of c-RET+ cells. The cell was
identified 15 h after plating (a), and
photographs of the same field were taken
every 24 h for the next 3 days (b–d).
Approximately 50% of the plated cells behave
in this way (see Table 1 and [14]). All images
were viewed using the 40× objective, except
for (d) which was viewed using the 20×
objective.
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colonies examined) of the clones contained at least some
GFAP+ glial cells after 14 days in culture (Fig. 2c,d). The
proportion of glial or smooth-muscle cell-containing clones
was not significantly increased by addition of GGF or
TGFb1, which promote glial and smooth muscle differen-
tiation, respectively, in NCSC cultures [15,17] (data not
shown). Taken together, these data indicate that, under
our standard culture conditions, at least some c-RET+
non-neuronal cells can generate smooth muscle or glia.
c-RET+ non-neuronal cells are competent for neuronal
differentiation
The observation that the non-neurogenic subset of
c-RET+ cells can differentiate into smooth muscle or glial
cells raised the question of whether these cells are com-
mitted to such non-neuronal fates. To address this ques-
tion, we challenged the cells by exposing them to BMP2, a
growth factor recently shown to promote autonomic
neurogenesis by uncommitted NCSCs [15] . 
In striking contrast to their behavior in control medium, in
the presence of BMP2 (50 ng ml–1) over 80% of c-RET+
cells differentiated to cells with a neuronal morphology
(Fig. 3). These cells expressed neuronal markers, such as
neurofilament and peripherin, as well as the autonomic
lineage marker B2 [18,19] (data not shown). A dose-
response experiment indicated that a half-maximal effect
of BMP2 was obtained at about 0.5 ng ml–1 BMP2 (Fig. 4a).
Figure 2
Some non-neuronal clones differentiate to
smooth muscle or glia. (a,b) Smooth muscle
differentiation in a non-neuronal clone fixed
after 4 days was revealed by double-staining
with antibodies to smooth muscle actin (FITC)
and calponin (rhodamine); (b) is an
epifluorescence image of the field revealed by
phase-contrast illumination in (a). Note that all
the cells in this clone co-express both
markers. Approximately 35% of the clones
contained such doubly labeled cells. (c,d)
Glial differentiation in an non-neuronal clone
fixed after 2 weeks was revealed by staining
with antibody to glial fibrillary acidic protein
(GFAP); (c) and (d) are phase-contrast and
epifluorescence images of the same
microscopic field, respectively. Approximately
10% of the clones contained such GFAP+
cells. All images were viewed using the 40×
objective.
Figure 3
BMP2-promoted neuronal differentiation in c-RET+ cells. BMP2
(50 ng ml–1) was added 3–4 h after plating. A single cell was identified
15 h after plating (a), and the same microscopic field was
photographed after 63 h (b) and 87 h (c). Note the process-bearing
neuronal morphology of the cells. Cells like those shown in (c)
expressed neuronal markers such as neurofilament or peripherin (not
shown). All images were viewed using the 40× objective.
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To determine whether the growth factor actually caused
the conversion of non-neuronal cells to a neuronal fate, or
simply supported the selective survival of neurogenic
clones at the expense of non-neuronal clones, we analyzed
the fates of cohorts of identified founder cells. In either the
presence or absence of BMP2, less than 10% of the clones
died (Fig. 4b), yet the fraction of neuronal clones increased
from less than 40% in control medium to over 90% in
BMP2; concomitantly, the proportion of non-neuronal
clones decreased from 50% to 10% and that of mixed
clones from about 15% to 0% (Fig. 4b). These results argue
that the increase in the percentage of neuronal clones
caused by BMP2 is due to the phenotypic conversion of
non-neuronal (and mixed) clones to neuron-only clones.
This, in turn, indicates that the subset of c-RET+ cells that
can generate non-neuronal derivatives (such as smooth
muscle or glia) under control culture conditions is never-
theless competent to undergo neuronal differentiation if
challenged with BMP2.
Competence to respond to BMP2 declines with time 
in vitro
The ability of c-RET+ cells to differentiate into neurons
when challenged with BMP2 progressively declined with
time in culture. When BMP2 was added 3 hours after
plating, 89 ± 5% of a cohort of identified c-RET+ founder
cells differentiated as neuron-only clones; by contrast, if
addition of BMP2 was delayed for 47 hours, only 51 ± 5%
of identified cells differentiated in this way (Table 1).
Conversely, the percentage of non-neuronal clones
increased, from 8 ± 5% to 38 ± 8%. Importantly, the per-
centage of cells or clones that died was ≤ 5% in all condi-
tions, indicating that delayed addition of BMP2 did not
simply lead to the selective death of neurogenic cells
(Table 1). These data suggest that the subset of c-RET+
Figure 4
Dose-dependence and instructive nature of the BMP2 effect. (a) At
each of the indicated concentrations of BMP2, a cohort of clones was
identified at the beginning of the experiment and the presence of
neurons determined after a 4 day incubation (shaded bars). In a
separate experiment, the proportion of clones containing any MASH1+
cells was determined by immunostaining after 67 h (white bars). The
values represent the mean ± S.D. of duplicate plates from two
independent experiments. The total number of colonies (from two
separate experiments) examined at each concentration of BMP2
averaged 117 (range 73–167) for MASH1 expression, and 222 (range
139–344) for neuronal differentiation. (b) Clonal analysis. A cohort of
founder cells was identified before addition of BMP2 (50 ng ml–1) 3 h
after plating and the fate of the colonies determined after a 4 day
incubation: ‘neuronal’ clones consisted purely of neurons; ‘mixed’
clones consisted of both neurons and non-neuronal cells; ‘non-neuronal’
clones consisted only of non-neuronal cells; and ‘dead,’ clones died
(usually within the first 24 h of the incubation). The increase in the
proportion of neuron-only clones in BMP2 (neuronal, compare the light
and dark shaded bars) and the concomitant decrease in the proportion
of non-neuronal clones, with a small and unchanging proportion of dead
clones, suggests that BMP2 converts non-neuronal to neuronal clones.
In two independent experiments, a total of 201 colonies were scored in
the control condition and 198 colonies in BMP2. Values represent the
mean ± range from the two experiments.
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Table 1
Responsiveness to BMP2 declines with time in clonal culture.
Clone composition
BMP2 Neuronal Mixed Non-neuronal Dead n
addition
None 37 ± 4% 12 ± 1% 48 ± 1% 5 ± 4% 201
3 h 89 ± 5% 0% 8 ± 5% 3 ± 0% 198
17 h 85 ± 6% 1 ± 1% 13 ± 3% 2 ± 2% 177
47 h 51 ± 5% 9 ± 1% 38 ± 8% 3 ± 3% 191
E14.5 c-RET+ cells were plated at colony density (300 cells per
35 mm dish) and a cohort of founder cells were identified and circled
17 h after plating. ‘BMP2 addition’ indicates that BMP2 (50 ng ml–1)
was added at the indicated times, or not at all (‘None’). At the end of a
4 day incubation, colonies were scored as containing only neurons
(neuronal), only non-neuronal cells (non-neuronal), a mixture of neurons
plus non-neuronal cells (mixed), or ‘dead’ (if the cells in the colony died
during the incubation; such death usually occurred within the first 24 h
after circling). The data represent the mean of two different
experiments, with duplicate dishes for each condition within each
experiment; n indicates the total number of clones analyzed for each
time point. The number of dead clones is small and invariant, implying a
time-dependent change in the interconvertibility of non-neuronal clones
to neuronal clones in response to BMP2.
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cells that are not already committed to a neuronal fate
lose neurogenic capacity with time in culture. The pro-
portion of mixed colonies (neuronal plus non-neuronal
cells) also increased when presentation of BMP2 was
delayed (Table 1, ‘mixed’), further suggesting that neuro-
genic potential is not always lost in a clonal or synchro-
nous manner.
Loss of neurogenic competence is paralleled by a decline
in MASH1 expression in non-neuronal cells
We next sought to understand in molecular terms why
most c-RET+ cells are initially competent for neurogenic
differentiation but progressively lose this capacity with
time in culture. Previously, we noted that approximately
85% of freshly isolated c-RET+ cells express detectable
levels of MASH1, although the level of expression varies
from cell to cell [14]. The proportion of c-RET+ cells that
differentiate into neurons in response to an early addition
of BMP2 (about 85–89%; Fig. 4 and Table 1) is similar to
the proportion of freshly-isolated cells that are MASH1+,
suggesting that expression of MASH1 may correlate with
competence to respond to BMP2. Moreover, in the
absence of BMP2, the proportion of non-neuronal cells
that express MASH1 declines: by 67 h in vitro, only
41 ± 10% (3 experiments, 168 colonies examined) of flat
cells expressed detectable levels of MASH1. These data
suggest that the decline in neurogenic capacity is reflected
in a gradual extinction of MASH1 expression. As
described below, functional perturbation experiments
suggest that maintenance of MASH1 expression by these
cells is causally related to maintenance of competence for
neuronal differentiation.
BMP2 maintains expression of MASH1 in vitro
The fact that BMP2 induces de novo expression of
MASH1 in NCSCs [15] suggested that this growth factor
might also maintain expression of MASH1 in the c-RET+
population. To address this issue, cells were cultured for
67 hours in varying concentrations of BMP2, and then
fixed and stained with anti-MASH1 antibody. In the
absence of BMP2, 59 ± 10% of non-neuronal clones were
MASH1– at 67 hours (Fig. 5a,b), whereas in the presence
of BMP2, 80–90% of these clones contained at least some
MASH1-expressing cells (Fig. 5c,d). A dose-response
experiment indicated that the concentrations of BMP2
which allowed maintenance of MASH1 expression were
similar to, but slightly lower than, those required for
induction of neuronal differentiation (Fig. 4a, white bars).
Taken together, these results suggested that the ability
of BMP2 to promote neuronal differentiation in c-RET+
cells is reflected in its ability to maintain MASH1
expression in these cells.
Constitutive expression of MASH1 maintains competence
to respond to BMP2
We next examined whether constitutive expression of
MASH1 from a retroviral vector in embryonic day 14.5
(E14.5) c-RET+ cells maintained competence for neuro-
genesis in response to a delayed presentation of BMP2.
Sequences encoding a Myc-epitope tag [20] were incorpo-
rated into the Mash1 transgene to distinguish the product
from endogenous MASH1. As a control, cells were
infected with a retrovirus encoding epitope-tagged E12, a
ubiquitously expressed bHLH protein [21] that hetero-
dimerizes with MASH1 [22] and other tissue-specific
Figure 5
BMP2 maintains expression of MASH1 in
non-neuronal colonies. (a,b) A non-neuronal
colony grown for 67 h in the absence of
BMP2 and fixed and stained for MASH1.
Most (60–65%) colonies fail to express
detectable MASH1, although a smaller
proportion expresses low but detectable
levels of the protein (data not shown). (c,d) A
nonneuronal colony grown for 67 h in the
presence of BMP2 (0.5 ng ml–1) and fixed and
stained for MASH1. Note the presence of
MASH1-immunoreactivity in the nuclei of the
cells. Most ( > 65%) of the colonies grown in
BMP2 were detectably MASH1-
immunoreactive (see Fig. 4a), although the
level of expression varied from cell to cell. All
images were viewed using the 40× objective.
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bHLH proteins, such as MyoD [23], as well as with
inhibitory HLH proteins such as Id [24]. Following infec-
tion, the cells were replated at clonal density to permit
identification of the non-neuronal subset. Approximately
2 days later (by which time most, or all, committed neu-
ronal precursors had already differentiated and could
therefore be excluded by their process-bearing morphol-
ogy), a cohort of non-neuronal colonies was identified and
circled. BMP2 was then added to some of the cultures.
After a further 2 day incubation, the cultures were fixed
and double-labeled for the 160 kDa neurofilament protein
(NF160) to reveal neuronal clones and for the Myc-
epitope tag (to reveal retrovirally infected colonies; Fig. 6).
In some experiments, peripherin was used as an alterna-
tive neuronal marker.
Cells expressing exogenous MASH1 showed a higher
likelihood of neuronal differentiation than control cells
when BMP2 was added after 67 hours in culture: 74 ± 8%
(92 colonies examined) of Myc-tag-positive colonies in
Mash1-retrovirus-infected cultures contained at least some
neurons; 58% of all Myc-tag-positive clones consisted
purely of neurons (Table 2 and Fig. 7a–c). These neuronal
cells expressed other markers, such as peripherin, in addi-
tion to neurofilament (not shown). By contrast, only about
27% of uninfected (Myc-tag-negative) clones in the same
cultures contained some neurons, and only 14% contained
exclusively neurons (Table 2). In E12-infected cultures
exposed to late addition of BMP2, only 34% of the Myc-
tag-positive clones contained some neurons, and only 24%
contained exclusively neurons. Almost 70% of the E12-
expressing clones contained only non-neuronal cells (Fig.
7d–f and Table 2). Furthermore, the proportion of neu-
ronal colonies in these E12-infected cultures was the same
whether the clones were Myc-tag-positive (infected) or
Myc-tag-negative (uninfected; see Table 2). That E12 had
no effect suggests that the effect of MASH1 reflects its
specific transcriptional activation function [22], and not
simply a sequestering of negative regulators [24]. Taken
together, these data suggest that constitutive expression of
MASH1 can maintain competence to differentiate to
neurons in response to BMP2. In the absence of BMP2,
however, expression of exogenous MASH1 was insuffi-
cient to promote neuronal differentiation (Table 2).
Discussion
In this paper we have investigated the relationship
between expression of MASH1, a bHLH transcription
factor essential for autonomic neurogenesis [25], and the
developmental potential of an isolated population of post-
migratory neural crest cells [14]. Our results indicate that
there is a correlation between expression of MASH1 and
competence for neuronal differentiation elicited by expo-
sure to BMP2. Expression of MASH1 declines with time
but can be maintained by continuous exposure to BMP2.
Competence for neuronal differentiation elicited by
BMP2 also declines with time but can be maintained by
constitutive expression of MASH1 from a retroviral vector.
These results suggest a self-reinforcing positive-feedback
interaction between the expression of MASH1 and the
action of BMP2, which may underlie progressive commit-
ment to neurogenesis (Fig. 8). In the absence of BMP2,
c-RET+ cells can differentiate to non-neuronal fates, such
as smooth muscle and glia. Thus, BMP2 appears to main-
tain a critical period for autonomic neuronal differentiation
in neural crest cells as they migrate through the gut. Such
a mechanism may be important in maintaining the pro-
tracted period of neurogenesis that occurs within this
tissue in vivo [26].
Figure 6
Schematic illustration of the design of the retroviral infection experiment;
see text and Materials and methods section for details. Approximately
20% of the cells were infected with the retrovirus (illustrated by shading),
but these were identified retrospectively by staining with an antibody to
the Myc tag. Non-neuronal clones cannot be prospectively identified at
the time of infection, but by 43 h after replating at clonal density, cells
which will generate neurons have done so and can be excluded from
further analysis by morphological criteria. At this time, cohorts of non-
neuronal clones were identified and circled, BMP2 added to some, and
the fate of these clones determined after a further 2 day incubation.
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Table 2
Forced expression of Mash1 in non-neuronal precursors maintains competence for neuronal differentiation in response to BMP2.
Mash1-infected E12-infected
BMP2: – + – +
Myc: – + – + – + – +
Neuron-containing colonies (%) 0 0 26 ± 8 74 ± 8 0 0 34 ± 13 34 ± 5
(% Neuronal only) 0 0 14 58 0 0 21 24
(% Neuronal plus non-neuronal) 0 0 13 15 0 0 13 9.5
Non-neuronal colonies (%) 100 100 74 ± 7 26 ± 8 100 100 66 ± 13 67 ± 5
Number of colonies (number of plates) 65 (2) 13 (2) 106 (6) 92 (6) 55 (2) 55 (2) 186(6) 231(6)
Figure 7
Forced expression of Mash1 but not of E12
promotes neuronal differentiation in the
presence of BMP2. (a–c) A clone from a
Mash1-infected culture grown in BMP2. All of
the cells express exogenous MASH1 (b)
(identified by nuclear staining with the anti-
Myc-tag antibody), have a process-bearing
morphology (a), and express neurofilament (c).
In other experiments, such neuronal colonies
also expressed other markers such as
peripherin (not shown). Approximately 60% of
the colonies in the experiment behaved in this
way (Table 2). Only 14% of uninfected (Myc-
tag-negative) colonies in the same dish
behaved this way (Table 2; not illustrated).
(d–f) A clone from an E12-infected culture
grown in BMP2. The E12-expressing cells are
identified by nuclear (and some cytoplasmic)
staining with the anti-Myc-tag antibody (e),
have a non-neuronal morphology (d) and do
not express neurofilament (f). Approximately
66% of the colonies in the experiment
behaved in this way (Table 2). Note that no
neuron-containing colonies were observed in
either the Mash1- or E12-expressing colonies
grown in the absence of BMP2 (Table 2). All
images were viewed using the 40× objective.
E14.5 c-RET+ cells were plated and analyzed according to the
experimental design schematically illustrated in Fig. 6. Briefly, the cells
were plated at high density for 15 h and then infected with Mash1- or
E12-encoding retrovirus (see Materials and methods section) in three
successive rounds. The cells were replated at 300 cells per 35 mm
dish; 43 h later, non-neuronal colonies were identified and circled and
BMP2 (50 ng ml–1) added to some dishes. After a further 2 day
incubation, the cultures were fixed and double-labeled with antibodies
to the Myc epitope tag and to neurofilament (see Fig. 7). In each plate,
20–30 identified colonies were characterized as either uninfected or
infected (Myc: – or +, respectively), and as containing neurons or only
non-neuronal cells. Neuron-containing colonies were further
subdivided into neuronal only or mixed neuronal plus non-neuronal
colonies. Numbers represent the mean ± S.D. from the indicated
numbers of colonies in a single representative experiment. The
experiment was repeated twice with similar results. Note that the
proportion of neuron-containing colonies in BMP2 is much higher
(74%) in MASH1-infected cells than in either uninfected cells in the
same plates (26%) or E12-infected colonies in separate plates (34%).
Function of MASH1 in c-RET+ cells
The fact that most or all c-RET+ cells initially express
MASH1, yet they can generate smooth muscle or glia,
indicates that expression of MASH1 is by itself insuffi-
cient to commit the cells irreversibly to a neuronal fate.
However, expression of MASH1 appears to underlie
competence to differentiate to neurons in response to
BMP2. Interestingly, forced expression of Mash1 in non-
neuronal cells did not promote neurogenesis on its own;
rather, it simply maintained responsiveness to BMP2. In
the context of c-RET+ cells, therefore, Mash1 behaves like
a true determination gene: it confers or maintains
competence to differentiate in a particular direction, but
this competence is a latent state that can only be revealed
by exposure of the cells to appropriate inducing signals.
The ability of Mash1 to confer or maintain the neurogenic
competence of progenitor cells is reminiscent of the
function of its homologs, the proneural genes of the
achaete–scute complex, in Drosophila. The initial expression
of achaete–scute occurs in a cluster of neuroectodermal cells
and is thought to confer on these cells competence for
neural differentiation. Subsequently, one of the cells in
this ‘proneural’ cluster achieves a higher level of proneural
gene expression than its neighbors, delaminates and
becomes a sensory organ precursor (for review, see [27]).
Thus, in the fly, as in mammals, expression of achaete–
scute/Mash1 alone is insufficient to commit cells to a neural
or neuronal fate; rather, it renders the cells competent to
express this fate in response to subsequent events.
In Drosophila, loss-of-function mutations in achaete–scute
revealed that these proneural genes are essential for forma-
tion of the sensory organ precursor [28], but did not address
the issue of competence. Evidence for a function in pro-
moting competence was established by mis-expression of
achaete–scute in the neurectoderm, which causes the appear-
ance of ectopic sensory bristles [29]. Similarly, analysis of
Mash1–/– mutant mice has revealed an essential function for
this gene in autonomic neurogenesis [11,25], but did not
exclude a function in conferring competence to adopt a
neuronal fate. The results presented here represent the
first gain-of-function data for Mash1. The detection of a
Mash1 gain-of-function phenotype stands in contrast to pre-
vious experiments in cell lines [8,13], and may reflect our
use of primary progenitor cells derived from a lineage in
which the gene is normally expressed. Similarly, in Droso-
phila, the ability of achaete–scute to promote ectopic sensory
bristle formation occurs only within highly restricted spatial
and temporal domains within the neurectoderm [29]. 
Earlier analysis of Mash1–/– mutants suggested that the
gene is required in autonomic neurogenesis only after
precursors are already committed to a neuronal fate and
express markers such as neurofilament and neuron-spe-
cific b-tubulin [11]. However, MASH1 protein is clearly
produced in progenitor cells that have not yet expressed
such neuronal genes, and which are not committed to a
neuronal fate ([14] and this study). The present data
suggest that the expression of MASH1 in these cells may
confer competence for neuronal differentiation. If so, then
MASH1 would act at several successive stages in neuroge-
nesis within the autonomic lineage. The failure to observe
an essential function for Mash1 at the earlier developmen-
tal stage in the null mutant may reflect the existence of
functionally redundant genes or other compensatory
mechanisms. Similarly, in Drosophila the loss-of-function
phenotype of achaete–scute is detected as a failure to
produce sensory organ precursor cells [28], even though
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Figure 8
Proposed roles of BMP2 and MASH1 in progressive commitment of
neural crest cells to an autonomic neuronal fate. Naive neural crest
stem cells do not initially express MASH1, but the transcription factor
is induced in these cells by BMP2 [15]. BMP2 is required to maintain
(and possibly increase) expression of MASH1 in c-RET+ cells.
MASH1, in turn, feeds back to maintain or enhance responsiveness to
BMP2. Eventually, the cells commit to a neuronal fate and differentiate
to neurons in the absence of exogenous BMP2, in a manner that
cannot be inhibited by GGF [14] or TGFb1 (L.L. and D.J.A.,
unpublished observations); c-RET+ cells cultured in the absence of
BMP2 eventually lose MASH1 expression and neurogenic capacity,
and differentiate to glia, smooth muscle or other unidentified non-
neuronal cell types. Delayed addition of BMP2 can rescue some of
these cells and divert them back to a neuronal fate, but this rescuability
declines with time (dashed arrows) and can be maintained by forced
expression of MASH1.
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the gene is also believed to function earlier, in conferring
neural competence on cells of the proneural cluster [30].
Although we cannot exclude the possibility that the func-
tion for Mash1 revealed here is an artifact of overexpress-
ing the gene, we feel this is unlikely given the correlation
between the expression of endogenous Mash1 and compe-
tence for neurogenesis elicited by BMP2. Rather, our
results underscore the need for both loss-of-function and
gain-of-function data in understanding the developmental
function(s) of a regulatory gene [5].
An unanswered question concerns the relationship be-
tween Mash1 expression and differentiation to smooth
muscle and glial fates. Initial expression of Mash1 in
c-RET+ cells does not preclude eventual differentiation of
some cells to these non-neuronal fates. However, the pro-
portion of smooth muscle and glia was not increased by
TGFb1 or GGF2, respectively, growth factors which
promote these lineages in NCSC cultures [15,17]. The
reason for the lack of responsiveness to these factors in the
post-migratory c-RET+ population is not clear. Although it
could be related to the expression of Mash1, responsiveness
to TGFb1 and GGF2 was not recovered during the culture
period when Mash1 is down-regulated (L.L. and D.J.A.,
unpublished observations). It was therefore not possible to
test in this system whether forced expression of Mash1
would inhibit responsiveness to TGFb1 or GGF2. We are
currently examining this issue in cultures of NCSCs.
Developmental potential and lineage relationships of
c-RET+ neural crest cells
Previously, we found that the c-RET+ population contains
a mixture of precursors committed to a neuronal fate, and
other precursors fated to generate non-neuronal cells
under the same conditions in vitro [14]. Here, we have
shown that these non-neuronal derivatives include smooth
muscle and glia, derivatives which are also produced by
more primitive neural crest stem cells under the same
culture conditions [15,16]. These observations raised the
possibility that the c-RET+ population, though antigeni-
cally homogeneous, comprises a mixture of progenitors
committed to either neuronal or non-neuronal fates. But,
in fact, our results indicate that virtually all c-RET+ cells
can adopt a neuronal fate in the presence of BMP2. The
antigenic homogeneity of the isolated population there-
fore reflects an underlying homogeneity in developmental
potential. The heterogeneity in overt neuronal differen-
tiation observed within the c-RET+ population, when cul-
tured without BMP2, may simply reflect asynchrony in
the extent of irreversible commitment to neurogenesis
among individual cells at the time of isolation. Such asyn-
chrony could reflect the extended period over which
neurogenesis normally occurs in the fetal gut [26].
Our results do not address the question of whether all
c-RET+ cells are normally fated to generate neurons in
vivo, or rather generate a mixture of neuronal and non-
neuronal derivatives as they do in vitro. The data suggest
that the actual fate of c-RET+ cells in vivo may simply
depend on whether they are exposed to BMP2 (or BMP4)
for a sufficient period of time. Our observations also
underscore the danger in inferring the extent of commit-
ment of neural crest cells simply on the basis of their
clonal fates in vitro, without challenging the cells by expo-
sure to factors that promote alternative fates. Even under
‘permissive’ conditions, cells may possess developmental
capacities that they do not reveal because of variations in
local microenvironment, stochastic events, or other uncon-
trolled variables.
A feedback interaction loop between BMP2 and MASH1
Our experiments point to an unexpected feedback inter-
action between MASH1 and BMP2. The present and pre-
vious work [15], taken together, indicate that BMP2 is
required for both induction and maintenance of Mash1
expression. In turn, continued expression of Mash1 in
progenitor cells maintains their capacity to respond to
BMP2. Thus, the growth factor and transcription factor
interact in a reciprocal manner to promote neurogenesis.
BMP2 induces Mash1; MASH1 in turn maintains or en-
hances responsiveness to BMP2; and BMP2 further pro-
motes continued expression of Mash1. In this way, BMP2
maintains competence to respond to itself, and MASH1
helps to sustain its own expression by maintaining respon-
siveness to BMP2. This linkage creates a self-reinforcing
positive-feedback loop that may help to drive the cells to a
neuronal fate (Fig. 8). If the cells are cultured on their
own until Mash1 expression declines, however, subse-
quent addition of BMP2 is unable to promote neurogen-
esis (Fig. 8, dashed arrows). This suggests that, if the
BMP2–MASH1 feedback loop is not maintained, an
apparently irreversible loss of neurogenic potential occurs.
The basis for this irreversible change is not understood.
Previous studies of bHLH gene regulation and function
have emphasized the importance of autoregulatory loops
[1,2]. In the case of achaete–scute and MyoD, these loops
are assumed to be implemented by binding of the tran-
scription factors to their own promoters [31–33]. Here, we
provide evidence for a positive-feedback loop in which
MASH1 indirectly reinforces its own expression by pro-
moting responsiveness to BMP2, a growth factor that in
turn induces and maintains expression of Mash1. The
incorporation of such an extracellular signal in a transcrip-
tion factor ‘autoregulatory’ loop would allow for greater
flexibility and amplification capacity in the control of such
a feedback circuit, and may prove to be a common mecha-
nism of cell fate determination in many systems.
Conclusion
The results described here suggest that the bHLH tran-
scription factor MASH1 may play at least two sequential
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roles during neurogenesis: it may confer or maintain the
competence to adopt a neuronal fate in uncommitted
cells, in response to signals such as BMP2; and it is
essential for the execution of neuronal differentiation in
precursors that are probably committed to this fate. In
addition, the progressive commitment of neural crest
cells to neurogenesis may involve a positive feedback
interaction between MASH1 and BMP2, in which the
transcription factor maintains responsiveness to the
growth factor, which in turn promotes expression of the
transcription factor. This type of reciprocal interplay
between cell-intrinsic and cell-extrinsic factors seems
likely to be a general feature of lineage commitment in
many systems.
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Materials and methods
Culture of c-RET+ cells
c-RET+ primary rat enteric precursor cells were isolated and cultured in
standard medium [16] as described [14]. Recombinant human BMP2
was a gift from Genetics Institute. Recombinant human TGF-b1 was
purchased from R&D Systems. Recombinant human GGF was a gift
from Cambridge Neurosciences [17]. 
Immunocytochemistry
Monoclonal antibodies to MASH1 [9], GFAP (Sigma), NF160 (Sigma),
a smooth muscle actin (Sigma), and calponin (Sigma) were used as
described [11,15,17]. Detailed immunostaining protocols are available
on request. Expression of smooth muscle markers was apparent after
4 days, whereas that of GFAP was not detected until after 14 days, the
usual incubation period required to observe GFAP expression in
NCSCs [17]. Because of the different incubation periods and staining
protocols employed, we did not examine the overlap between glial and
smooth muscle fates in these experiments. Hybridoma cells producing
monoclonal antibodies to the  human c-Myc epitope (clone Myc 1-
9E10.2) were obtained from the ATCC. Cultures were incubated for
18 h at 4°C in anti-Myc-tag hybridoma supernatant diluted 1:1 with
standard culture medium, followed by a horse radish peroxidase-conju-
gated goat anti-mouse IgG (Chemicon). 
Construction of pBABE retroviral vectors
Vector constructions were performed using standard molecular cloning
techniques. Mash1 and E12 cDNAs were cloned in-frame with an
amino-terminal Myc-epitope tag into a novel retroviral vector called
pBabeMT.APPuro. This vector is a modification of the pBabe puro
vector described in [34], in which the selectable marker (puromycin
resistance) is under the control of an internal SV40 promoter–enhan-
cer, and the foreign coding sequences are under control of the viral
LTR. This plasmid was modified to contain an internal ribosome entry
site (IRES)—human placental alkaline phosphatase cassette down-
stream of the cloning site, and a Myc-epitope tag (derived from the
plasmid pCS2+MT [35]) upstream of it. This vector allows immuno-
detection of virally infected cells using antibodies either to alkaline
phosphatase, which is expressed on the cell surface, or to the Myc-
epitope tag which is fused in-frame to the gene of interest. A detailed
restriction map for this vector is available upon request. Viral super-
natants for infection were produced by transient transfection in BOSC-
23 cells as described [36].
Retroviral infection of c-RET+ cells
Examination of the effect of constitutive expression of Mash1 from a
retroviral vector on the neurogenic capacity of the non-neuronal subset
of c-RET+ cells was complicated by a number of factors: firstly, only a
fraction of the cells (10–20%) exposed to the recombinant retrovirus
are infected, and it could not be prospectively determined which cells
were infected; secondly the non-neurogenic population represents a
subset (about 50%) of the c-RET+ cells and these cannot be prospec-
tively identified (that is, distinguished from the subset already commit-
ted to differentiate to neurons) at the time of retroviral infection. We
therefore adopted a strategy in which retroviral infection was followed
by analysis at clonal density (see Fig. 6), and retrospective identifica-
tion of virally-infected cells using antibody to the Myc-epitope tag incor-
porated into the heterologous gene (Mash1 or E12). This experimental
design incorporates two types of control: an internal control, in which
the proportion of neuronal colonies is compared between infected and
uninfected colonies in the same plate, and an external control in which
the proportion of neuronal colonies is compared between Myc-tag+
cells in Mash1-infected and E12-infected cultures.
Approximately 5 000 freshly isolated E14.5 RET+ enteric cells were
plated on a poly-D-lysine/fibronectin substrate [16] in a glass cloning
cylinder (3 mm inner diameter) located in the center of a 35 mm dish.
The cloning cylinder and medium were removed after an overnight incu-
bation and Mash1- or E12-expressing retroviral supernatants were
diluted 1:1 with standard medium (SM) [16] and added to the cells.
After a 3 h incubation at 37°C, the viral solution was removed and the
culture was washed once with fresh SM. Cells were allowed to recover
in SM for 1 h and the infection procedure repeated for two more
rounds. Following infection, cells were washed three times with SM
and removed from the dishes with a 0.05% trypsin solution
(GIBCO/BRL). The cells were counted and replated at 300 cells per
35 mm dish on poly-D-lysine/fibronectin. Approximately 2 days after
replating, most neuron-containing clones had already differentiated and
could therefore be identified and excluded by their process-bearing
morphology. A cohort of non-neuronal colonies was then identified and
circled; such colonies never differentiated into neurons if the incubation
was continued for 2 more days in the absence of BMP2 (Table 2).
BMP2 (50 ng ml–1) was added to some of the cultures. After 2 more
days of incubation, the cells were fixed and stained for the Myc-epitope
tag to reveal the expression of Mash1 or E12 transgenes and counter-
stained with anti-NF160 to reveal the presence of neurons.
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